Biotechnology News

November 14, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company’s presentation at the Piper Jaffray Healthcare Conference in New York, New York on November 28, 2012. The live webcast is scheduled to begin...

November 14, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today reported the financial results for...

November 14, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Scouts New Biotech Innovations at NIBA Investment Conference

November 14, 2012

MUNICH--(BUSINESS WIRE)--Only weeks after the release of Buzz™—the newest Brainlab innovation for the digital operating suite—Brainlab announced today a watershed agreement with the Großhadern Clinic branch of the Hospital of the University of...

November 14, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Fingerprint Cards (FPC)(STO:FINGB) has opened its first US-based sales- and support office in San Francisco, California, and hired Charles Ng as Sales Director North America. Charles previous employer...

November 14, 2012

BAGNEUX, France--(BUSINESS WIRE)--Regulatory News: DBV Technologies, (Euronext: DBV – ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergies, announced today the launch of its third Viaskin programme in the...

November 13, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE MKT: NAVB) Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission

November 13, 2012

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate presentation will be webcast from the 2012 Credit Suisse Healthcare Conference in Phoenix. John F. Milligan, PhD, Gilead’s President and...

November 13, 2012

LOS ANGELES--(BUSINESS WIRE)--KYTHERA Biopharmaceuticals third quarter 2012 financial results

November 13, 2012

INDIANAPOLIS--(BUSINESS WIRE)--YourEncore today launched a new solution that will help pharmaceutical companies make more informed decisions about whether and how to proceed with Phase III trials.

November 13, 2012

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG) today presented the results from PALACE-1, the Company’s first Phase III study in psoriatic arthritis, at the American College of...

November 13, 2012

HUBBARD, Ohio--(BUSINESS WIRE)--NanoLogix (OTC Markets: NNLX) is the subject of a featured news article released last week by the US Environmental Protection Agency. The article covers the progress of an ongoing Cooperative Research and...

November 13, 2012

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp signs collaborative research agreement with US FDA to extend Dog Simulator to veterinary medicines

November 13, 2012

DANVERS, Mass.--(BUSINESS WIRE)--NeuroLogica Corporation, the only manufacture of portable computer tomography solutions, is pleased to announce the Health Canada clearance for the portable CT scanner, BodyTom®.

November 13, 2012

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--A recent survey found that pharmaceutical manufacturers increased the involvement of digital media in their marketing mixes from 27.6% in 2009 to 48.8% in 2011.

November 13, 2012

WASHINGTON--(BUSINESS WIRE)--A team of researchers have created a new artificial lens that is nearly identical to the natural lens of the human eye and may one day help replace damaged or diseased human eye lenses.

November 13, 2012

AURORA, Colo. & INGELHEIM, Germany--(BUSINESS WIRE)--BaroFold and Boehringer Ingelheim have entered into an agreement where Boehringer will get a reactor of BaroFold's PreEMT technology that is qualified for GMP use for biologic drug...

November 13, 2012

DEERFIELD, Ill.--(BUSINESS WIRE)--The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.45 per Baxter common share. The dividend is payable on January 3, 2013 to shareholders of record as of...

November 13, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--A new study shows that Sciton BroadBand Light (BBL™) treatments can change the expression of genes associated with the aging process to more closely resemble young skin.

November 13, 2012

DENVER--(BUSINESS WIRE)--Corgenix Medical Corporation achieved record operating results for the quarter ended September 30, 2012. The company's Q1 FY 2013 financial results show record revenues, net income and EBITDA.

November 13, 2012

PARIS--(BUSINESS WIRE)--Phase I Independent Data Monitoring Committee confirms good safety of NBTXR3 in the first group of patients with advanced Soft Tissue Sarcoma

November 13, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Great Basin Corporation, a privately-held molecular diagnostics company developing sample-to-result solutions, today announced the opening of a new manufacturing facility. Dedicated to the manufacture of the...

November 13, 2012

DENVER--(BUSINESS WIRE)--The Colorado BioScience Association (CBSA) has announced finalists for the 'Rising Star of the Year' company award at its 2012 Awards Dinner Celebration -- Thursday, December 6.

November 13, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluxion Biosciences, Inc. announced today that it has launched its IsoFlux System for circulating tumor cell (CTC) analysis at the 3rd annual World CTC Summit in Boston. The system is now commercially...

November 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced that data from preclinical studies evaluating LG-7501 were featured in a poster presentation today at the 63rd Annual Meeting of the American Association for...

November 13, 2012

FORT LEE, N.J.--(BUSINESS WIRE)--US approves SAFE-BioPharma as one of four government-approved Trust Framework Providers available to Credential Service Providers and Identity Providers issuing cyber-identities

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--OvaScienceSM, (OTCBB: OVSC), a life sciences company focused on the discovery, development and commercialization of new treatments for infertility, today reported financial results for the quarter ended...

November 13, 2012

THE WOODLANDS, Texas--(BUSINESS WIRE)--Opexa Therapeutics, Inc., a company developing Tcelna™, a novel T-cell therapy for multiple sclerosis (MS), today announced that Health Canada has approved the Company's Clinical Trial Application.

November 13, 2012

HACKENSACK, N.J.--(BUSINESS WIRE)--ADMA Biologics, Inc. (ADMA), a late-stage biotechnology company focused on the development and commercialization of human plasma and plasma-derived therapeutics, today reported financial results for its third...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera announces initiation of Phase 1 trial of IMO-8400, a TLR antagonist with a novel mechanism of action to treat lupus

November 13, 2012

EXTON, Pa.--(BUSINESS WIRE)--Nuron Biotech has completed enrollment in a Phase 3 clinical trial evaluating a proprietary human interferon beta-1b (NU100) for the treatment of relapsing remitting multiple sclerosis.

November 13, 2012

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Murad Inc. announced that Fred Gysi has joined the Murad Family as Chief Financial Officer.

November 13, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--KineMed receives technology award from Frost & Sullivan for accelerating the drug development process, enhancing clinical management of patients and enabling discovery of new therapies

November 13, 2012

ROCKFORD, Ill.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Winter/Spring semester application deadline for its Thermo Scientific Pierce Scholarship program, which provides educational...

November 13, 2012

SAN JOSE, Calif. & VALENCIA, Calif.--(BUSINESS WIRE)--Colby Pharmaceutical Company and MannKind Corporation (Nasdaq: MNKD) today announced a license agreement granting Colby exclusive worldwide rights to develop and commercialize disease-...

November 13, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions to present at the Credit Suisse 2012 Healthcare Conference on November 15, 2012 beginning at 9:30 am EST

November 13, 2012

MIAMI--(BUSINESS WIRE)--ERBA Diagnostics, Inc. (NYSE MKT: ERB), a fully integrated in vitro diagnostics company, is pleased to announce its participation at the MEDICA Conference in Dusseldorf, Germany, during November 14th - 17th, 2012. The...

November 13, 2012

STATE COLLEGE, Pa.--(BUSINESS WIRE)--INDIGO Biosciences, Inc. has added all nine retinoid receptor assays to the company’s significant suite of kits and screening services.

November 13, 2012

LIVERMORE, Calif.--(BUSINESS WIRE)--Compact Particle Acceleration Corporation announces that following technical breakthroughs, it has received a letter of intent for delivery of a proton therapy system to Southwest Oncology Centers.

November 13, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics today announced the appointment of Peter Wirth, former Executive Vice President, Legal and Corporate Development, Chief Risk Officer and Corporate Secretary of Genzyme, as Chairman of the...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that due to the continued progress in its manufacturing operations this year, its supply of Thyrogen® (thyrotropin alfa for injection) has...

November 13, 2012

SAN DIEGO--(BUSINESS WIRE)--Epic Sciences completed a Series B financing to develop highly sensitive companion diagnostics to detect circulating tumor cells and monitor and personalize cancer treatments.

November 13, 2012

TORONTO--(BUSINESS WIRE)--Many segments of the European neurosurgical and neurovascular device market face significant challenges from competing treatments, and as a result the overall market will grow only slowly through 2016

November 13, 2012

TORONTO--(BUSINESS WIRE)--SQI Diagnostics’ multiplexing improves efficiency of drug development, clinical trials and immunogenicity testing
SQI Diagnostics to Present at the European Bioanalysis Forum Open Symposium

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Blueprint Medicines, a company harnessing the understanding of the molecular blueprint of cancer to develop personalized, highly-selective cancer therapies, today announced the addition of Daniel S. Lynch as...

November 13, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced today that its Enzo Clinical Labs has introduced a new diagnostic test that assists in risk assessment and early detection of lung cancer. It is being made available to physicians...

November 13, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem announced third quarter 2012 financial results.

November 13, 2012

RICHMOND, Va. & LONDON & SYDNEY--(BUSINESS WIRE)--AmpliPhi and Special Phage Services are formally combined. Ampliphi combines expertise in bacteriophage therapies to create a pipeline of anti-bacterials to address antibiotic resistant...